The Global Vaccine Summit, hosted by the UK, raises US$ 8.8 billion to immunise 300m children and support the global fight against COVID-19.
- The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of the Boris Johnson, Prime Minister of the United Kingdom of Great Britain and Northern Ireland. The meeting was held by videoconference in light of the ongoing COVID-19 pandemic.
- The funding will help immunise 300 million more children in lower-income countries against diseases like measles, polio and diphtheria by the end of 2025. It will also support health systems to withstand the impact of coronavirus and maintain the infrastructure necessary to roll out a future COVID-19 vaccine on a global scale.
- The Summit brought together more than 300 people, including 42 Heads of States and Governments. 52 countries were represented, notably 14 Gavi implementing countries, all of the G7 nations and 19 governments of the G20. Also many business leaders, UN agencies, civil society, government ministers, Heads of State and country leaders participated.
Eminent participants also included H.E. Antonio Guterres, Secretary-General of the United Nations; H.E. Dr Tedros Adhanom Ghebreyesus, WHO Director-General; H.E. Henrietta Fore, UNICEF Executive Director; Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation; Ministers from implementing and donor countries; CEOs of vaccine manufacturing companies and private sector partners; leaders of UN and other international agencies; senior civil society representatives; and Gavi champions.
- India pledged 15 Million US Dollars to Gavi, the international vaccine alliance.
- Besides receiving strong endorsements from long-standing Gavi donors, the Summit welcomed eight new sovereign donors who made pledges to Gavi for the first time, including Bhutan, Burkina Faso, Cameroon, Finland, Greece, New Zealand, Portugal and Uganda.
- Participants also welcomed new commitments made by the pharmaceutical industry to further invest in R&D and production and supply a range of vaccines in significant quantities to Gavi
- The Summit also discussed the global response to COVID-19. Kate Bingham, Head of the UK Vaccine Task Force, set out the challenges and opportunities that a vaccine against COVID-19 would present.
- Dr Berkley announced the launch of the COVID-19 Global Vaccine Access Facility (COVAX Facility). Its objective is to accelerate equitable access to appropriate, safe and efficaciousCOVID- 19 vaccines for all countries. Higher income countries will use domestic resources to contribute funds to the advance purchase guarantees and will purchase vaccines side by side with Gavi- supported countries who will use ODA resources. Manufacturers’ interest was recognized, as producers are seeking volume guarantees to scale production and understanding the risk of only serving a few countries in times of global pandemic and want to work with the Facility. AstraZeneca made the first private sector commitment to the Covax facility with 300 million doses of vaccine if it is successful guaranteed for the COVAX Facility.
- Covax, is a new innovative financing instrument to provide access to COVID-19 vaccines for low- and middle-income countries. This is the first building block towards a global mechanism to ensure equitable access to future COVID-19 vaccines.
About Gavi, the Vaccine Alliance: Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases.
Since its inception in 2000, Gavi has helped to immunise a whole generation – over 760 million children – and prevented more than 13 million deaths, helping to halve child mortality in 73 developing countries. Gavi also plays a key role in improving global health security by supporting health systems as well as funding global stockpiles for Ebola, cholera, meningitis and yellow fever vaccines.
The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation and other private sector partners
Gavi, the Vaccine Alliance, helps vaccinate almost half the world’s children against deadly and debilitating infectious diseases